| Literature DB >> 22829775 |
David E Shore1, Christopher E Carr, Gary Ruvkun.
Abstract
Many genetic and physiological treatments that extend lifespan also confer resistance to a variety of stressors, suggesting that cytoprotective mechanisms underpin the regulation of longevity. It has not been established, however, whether the induction of cytoprotective pathways is essential for lifespan extension or merely correlated. Using a panel of GFP-fused stress response genes, we identified the suites of cytoprotective pathways upregulated by 160 gene inactivations known to increase Caenorhabditis elegans longevity, including the mitochondrial UPR (hsp-6, hsp-60), the ER UPR (hsp-4), ROS response (sod-3, gst-4), and xenobiotic detoxification (gst-4). We then screened for other gene inactivations that disrupt the induction of these responses by xenobiotic or genetic triggers, identifying 29 gene inactivations required for cytoprotective gene expression. If cytoprotective responses contribute directly to lifespan extension, inactivation of these genes would be expected to compromise the extension of lifespan conferred by decreased insulin/IGF-1 signaling, caloric restriction, or the inhibition of mitochondrial function. We find that inactivation of 25 of 29 cytoprotection-regulatory genes shortens the extension of longevity normally induced by decreased insulin/IGF-1 signaling, disruption of mitochondrial function, or caloric restriction, without disrupting normal longevity nearly as dramatically. These data demonstrate that induction of cytoprotective pathways is central to longevity extension and identify a large set of new genetic components of the pathways that detect cellular damage and couple that detection to downstream cytoprotective effectors.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22829775 PMCID: PMC3400582 DOI: 10.1371/journal.pgen.1002792
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Gene inactivations that inhibit cytoprotective responses.
| p | p | p | p | ||
| tunicamycin | antimycin |
| azide | ||
| Gene | Fluorescence (fold decrease) | Function | |||
| C06A8.2 |
|
| ns | ns | Transcription; SNAPc |
|
|
|
| ns |
| RAS GTPase; endocytosis |
|
|
|
|
| ns | 20S proteasome, regulatory subunit |
|
|
| ns | ns | ns | Serine/threonine protein kinase |
|
|
|
| ns | ns | mRNA cleavage and polyA specificity |
| Y50D7A.11 |
|
| ns | ns | Uncharacterized |
| F18F11.5 |
| ns | ns |
| Serine/threonine protein kinase |
|
|
|
| ns |
| Transcription; mediator |
| F53F4.11 |
| ns | ns | ns | Uncharacterized |
|
|
|
| ns |
| Sphingolipid synthesis |
|
|
|
|
|
| mRNA cleavage and polyA specificity |
|
|
|
| ns | ns | Importin alpha nuclear transport factor |
|
|
|
|
|
| Transcription factor; intestinal |
|
|
|
|
|
| E2 ubiquitin conjugation enzyme |
|
|
| ns | ns | ns | Kinase; ER UPR |
|
| ns |
| ns | ns | Ubiquitin fusion degradation |
|
| ns |
| ns | ns | mRNA cleavage and polyA factor |
|
| ns |
|
|
| Serine/threonine protein phosphatase |
|
| ns | ns |
|
| ADP-ribosylation factor |
|
| ns | ns |
| ns | Transcription; mediator |
|
| ns | ns |
| ns | Serine/threonine protein kinase |
|
| ns | ns |
| ns | Transcriptional repression; dosage comp. |
|
| ns | ns |
| ns | Trehalose synthesis |
|
| ns | ns |
|
| Mevalonate synthesis |
|
| ns | ns |
| ns | Histone deacetylase |
|
| ns | ns |
| ns | Deacetylase; NuRD complex |
|
| ns | ns |
|
| Deacetylase; NuRD complex |
|
| ns | ns |
| ns | Transcription factor; insulin/IGF-1 sig. |
|
| ns | ns | ns |
| Ubiquitin ligase complex component |
|
| ns | ns | ns |
| Ubiquitin ligase complex component |
|
| ns | ns | ns |
| Transcription factor; stress, detox |
|
| ns | ns | ns |
| Serine/threonine protein kinase |
Expression of stress-responsive promoter::gfp fusions was quantified following treatment with an inducing toxin or genetic disruption of insulin/IGF-1 signaling. The ER UPR gene hsp-4 is induced by the inhibitor of N-linked glycosylation tunicamycin (column 1), the Mt UPR gene hsp-6 by the ETC complex III inhibitor antimycin (column 2), the superoxide dismutase sod-3 by temperature sensitive inactivation of the daf-2(e1370) insulin/IGF-1 receptor (column 3) and the detoxification and oxidative stress response gene gst-4 by the ETC complex IV inhibitor sodium azide (column 4). Treatments were applied to day 1 adult animals raised at 20°C. RNAi clones targeting ∼1500 candidate genes were screened for suppression of GFP expression under inducing conditions. All candidates were screened in three primary replicates of 50 animals and phenotypes were verified in five or more additional replicates. Phenotypes of 29 gene inactivations found to inhibit the induction of at least one cytoprotective pathway were quantified using the automated Molecular Devices ImageXpress Micro imaging platform. Fold decrease in fusion gene expression was quantified against vector-treated controls. Data represents the fold decrease in median expression in 4 to 8 replicates of 50 animals. For clarity, results that did not meet our threshold of significance (ns) are not shown. The symbol >>> denotes that sample fluorescence values did not differ significantly from background, precluding the quantification of fold change. We identify 15 genes required for expression of hsp-4 following treatment with tunicamycin (column 1), 14 genes required for expression of hsp-6 following treatment with antimycin (column 2), 14 genes required for expression of sod-3 in a temperature shifted daf-2ts mutant (column 3), and 15 genes required for expression of gst-4 following treatment with sodium azide (column 4) with significant overlap amongst functions (Figure S3). Results include well-studied canonical regulators of cytoprotective functions, including ire-1, daf-16 and skn-1, which act specifically in the hsp-4, sod-3 and gst-4 stress response pathways, respectively. Regulation of the expression of the heat shock response phsp-16.2::gfp in response to 1 hour treatment of 37°C and expression of a constitutively expressed non-stress-responsive psur-5::gfp were quantified as controls (Table S4). Expression of endogenous loci was quantified by qPCR (Table S5).
Figure 1Xenobiotic response regulatory factors are specific to one or more cytoprotective pathways.
Animals carrying promoter::gfp fusions to genes in key cytoprotective responses were exposed to stimuli that normally induce the expression of these constructs. These include hsp-4, an ER UPR gene induced by treatment with tunicamycin (column 1), hsp-6, an Mt UPR gene induced by treatment with antimycin (column 2), sod-3, an oxidative stress response gene induced in a temperature-sensitive daf-2 mutant background (column 3), and gst-4, an oxidative stress response and detoxification gene induced by treatment with sodium azide (column 4). Gene inactivations found to inhibit the expression of one or more of these gfp fusions include RNAi of wnk-1 (row 2, suppresses hsp-4 response), phi-50 (row 3, suppresses sod-3 and gst-4 responses), ima-3 (row 4, suppresses hsp-4 and hsp-6 responses), gob-1 (row 5, suppresses sod-3 response), elt-2 (row 6, suppresses hsp-4, hsp-6, sod-3 and gst-4 responses), let-70 (row 7, suppresses hsp-4, hsp-6, sod-3 and gst-4 responses), nekl-2 (row 8, suppresses gst-4 response), mdt-26 (row 9, suppresses hsp-4, hsp-6 and gst-4 responses) and pas-3 (row 10, suppresses hsp-4, hsp-6 and sod-3 responses). Representative images of conditions with decreased cytoprotective gene expression are outlined in red, and the fold reduction in GFP expression, quantified in Table 1, is shown in the lower right. None regulate the expression of the constitutively expressed gene fusion psur-5::gfp and only elt-2 regulates expression of the heat shock responsive gene fusion phsp-16.2::gfp, suggesting specificity to stress functions (Table S4). Endogenous gene expression was measured by qPCR (Table S5).
Cytoprotective gene regulation is essential to lifespan extension by diverse mechanisms.
| Control |
|
|
| Control |
|
|
| |
| Mean Lifespan (Days) | Δ Lifespan | Δ Lifespan Extension | ||||||
| Control | 18.1 | 27.0 | 26.2 | 38.7 | 0% | 0% | 0% | 0% |
|
| 12.9 | 13.6 | 14.5 | 16.4 | −29% |
|
|
|
|
| 16.9 | 18.5 | 18.1 | 22.2 | −7% |
|
|
|
|
| 16.5 | 19.6 | 18.2 | 24.4 | −9% |
|
|
|
|
| 14.4 | 16.7 | 15.4 | 25.3 | −21% |
|
|
|
|
| 16.8 | 19.3 | 19.5 | 30.2 | −7% |
|
|
|
|
| 17.1 | 21.6 | 19.1 | 30.9 | −6% |
|
|
|
|
| 17.2 | 19.1 | 18.2 | 32.2 | −5% |
|
|
|
|
| 15.7 | 22.5 | 19.6 | 29.4 | −14% | ns |
|
|
|
| 20.8 | 26.9 | 26.3 | 39.1 | 14% |
|
|
|
|
| 18.1 | 20.8 | 22.7 | 34.5 | 0% |
|
|
|
|
| 17.3 | 19.3 | 19.4 | 47.2 | −5% |
|
| ns |
|
| 16.8 | 18.3 | 19.2 | 33.1 | −7% |
|
| ns |
|
| 13.7 | 17.5 | 15.7 | 33.5 | −24% |
|
| ns |
|
| 15.7 | 19.0 | 18.8 | 32.4 | −14% |
|
| ns |
|
| 18.0 | 24.9 | 22.1 | 40.8 | −1% |
|
| ns |
| C06A8.2 | 17.1 | 22.4 | 21.8 | 33.9 | −6% |
|
| ns |
|
| 19.1 | 23.4 | 25.1 | 38.1 | 5% |
|
| ns |
|
| 15.5 | 18.6 | 20.7 | 35.7 | −14% |
|
| ns |
| Y50D7A.11 | 19.0 | 27.8 | 26.2 | 37.8 | 5% | ns |
| ns |
|
| 13.3 | 17.1 | 18.4 | 36.4 | −27% |
|
| ns |
|
| 12.7 | 13.5 | 17.5 | 34.2 | −30% |
| ns | ns |
|
| 16.2 | 20.1 | 24.2 | 37.8 | −11% |
| ns | ns |
|
| 17.3 | 23.1 | 25.6 | 38.7 | −5% |
| ns | ns |
|
| 17.6 | 24.6 | 25.9 | 41.9 | −3% |
| ns | ns |
| F53F4.11 | 19.4 | 27.5 | 29.4 | 38.7 | 7% |
| ns | ns |
|
| 18.6 | 26.6 | 27.6 | 37.9 | 2% | ns | ns | ns |
|
| 18.9 | 30.0 | 29.4 | 39.6 | 4% | ns | ns | ns |
| F18F11.5 | 17.6 | 29.6 | 26.9 | 43.3 | −3% | ns | ns | ns |
|
| 18.3 | 28.6 | 26.1 | 39.6 | 1% | ns | ns | ns |
Twenty-nine gene inactivations required for the appropriate induction of cytoprotective responses following stress (Table 1) were screened for lifespan phenotypes. Each gene inactivation, or an empty-vector RNAi control, was fed to wild-type (N2) animals and each of three long-lived mutants, including the isp-1;ctb-1 mitochondrial mutant, daf-2 insulin/IGF-1 signaling mutant and eat-2 feeding-defective mutant. Lifespan was measured in three replicates comprising an average of 103 worms per condition. Data is presented as mean lifespan (columns 1–4), change mean lifespan in comparison to an empty vector RNAi control (column 5), or as the change in the extension of lifespan induced by each long-lived mutant (columns 6–8; for clarity, only decreases >15% are shown). Only 5 of the 29 gene inactivations result in a 15% or greater reduction in wild-type (N2) lifespan, and most (20 of 29) reduce wild-type lifespan by less than 10% (column 5). Of the 29 genes, 25 demonstrate a significantly greater effect in at least one long-lived mutant background, and 16 gene inactivations abrogate 50% or more of the lifespan extension normally induced by at least one of the tested mutant backgrounds. Because these gene inactivations have small effects on wild-type lifespan but large effects on lifespan extension in long-lived mutant backgrounds, we propose that these gene inactivations are not simply progeric but instead play specific roles in lifespan extension.
Figure 2Loss of cytoprotective gene activation dramatically reduces lifespan extension in long-lived mutants but not controls.
Lifespans of animals treated with empty-vector RNAi or with inactivation of wnk-1 (A), ima-3 (B), elt-2 (C), pas-3 (D), phi-50 (E) and let-70 (F) were determined from three replicates comprising, an average of 103 worms per condition. Lifespan was measured in wild-type N2 controls (black lines) and three long-lived mutants, including a mitochondrial mutant (isp-1;ctb-1, orange lines), an insulin/IGF-1 signaling mutant (daf-2, blue lines) and a feeding mutant that models caloric restriction (eat-2, green lines). Data for control (empty vector-fed) animals of each strain are represented by solid lines and RNAi-treated animals by dashed lines. Inactivation of these cytoprotective response regulatory genes dramatically reduces lifespan extension in at least one long-lived mutant background, but not in wild-type controls.
Figure 3Regulation of cytoprotective gene activation is required for xenobiotic stress tolerance.
Genes found to regulate cytoprotective responses in our screen were inactivated in rrf-3ts sterile mutant animals. Animals were raised to day 3 adulthood on solid media and transferred to solution containing sublethal (∼LD30) treatments of 24 mg/ml paraquat (A), 22 µg/ml sodium azide (B), 5.2 mg/ml cadmium chloride (C), 696 µg/ml antimycin (D) or solvent alone (Figure S4). Animals were incubated in solution for 18 hours and survival was measured by spontaneous movement. An average of 94 animals were scored for each condition. Control samples treated with empty vector (L4440) RNAi are shown in red, with all other samples treated with gene inactivations that disrupt cytoprotective responses. Gene inactivations are ordered by decreasing survival within each panel. Phenotypes demonstrated by inactivation of nekl-2, mdt-26, wnk-1, phi-50 and elt-2 are amongst the most robust. Gene inactivations do not reduce survival in the presence of solvent alone (Figure S4). Error bars display S.D., asterisks indicate significantly decreased survival, p<0.05.